With coronavirus cases around the world now at over 16 million, scientists have been working around the clock to develop a treatment.
Now, a new study suggest that an arthritis drug could be the breakthrough we’ve all been waiting for. Researchers from Imperial College London say that a drug called tocilizumab could treat Covid-19 by halting the immune system ‘storm’ that the body produces in response to infection.
The drug is being tested on 450 coronavirus patients around the world. Dr Levi Garraway, Chief Medical Officer at Roche, which makes the drug, said: “As more information about COVID-19 pneumonia becomes available in these unprecedented times, it is more important than ever to work together to fight this disease. “Based on our